Q: Why should we decriminalize buprenorphine when people should just go to their doctor and get a legitimate prescription instead?
A1: Up until a few weeks ago, not all doctors or other providers with prescription privileges COULD prescribe this medication.
A1 cont'd:
Since ~2000, doctors and other providers with prescription privileges had to take several hours of training and submit paperwork in order to be granted an X-waiver - special permission to prescribe buprenorphine.
This deterred busy docs because it was a hassle.
A1 cont'd:
Check out this map from a recent study that showed many parts of the nation don't even have a single X-waivered prescriber.
A2: Even if your provider has an X-waiver, chances are they may not actually be writing buprenorphine prescriptions to many of their patients. Or at all.
STUDY: Less than 5% of waivered doctors are prescribing to the bulk of patients in the US.
A2 cont'd: Even if a provider has an X-waiver, there are huge racial disparities in who actually gets a prescription.
STUDY: Black patients were 77% less likely to get a buprenorphine prescription than white patients jamanetwork.com/journals/jamap…
A2 cont'd:
Black pregnant people with opioid use disorder were 76% less likely to get a buprenorphine prescription that white; Latinx pregnant people were 66% less likely. jamanetwork.com/journals/jaman…
A2 cont'd:
Black veterans receiving care in the Veterans Health Administration were less likely to get started on buprenorphine. doi.org/10.1080/088970…
A2 cont'd:
STUDY: Black youth who had an opioid overdose were 85% less likely to get a prescription, and estimate could not be calculated for Latinx youth because 0 in study got one. jamanetwork.com/journals/jamap…
A3: Even if your doctor writes you a prescription for buprenorphine, your pharmacy may not fill it!
Paper in NEJM: Pharmacists fear DEA prosecution for filling prescriptions, lack training about OUD, are suspicious of local prescribers and patients nejm.org/doi/10.1056/NE…
A3 cont'd:
STUDY: Doctors often have troubling interactions with pharmacists who are overreaching doi.org/10.1080/108260…
A3 cont'd:
STUDY: Pharmaceutical distributors fear the DEA coming after them, so their preemptive measures to deter opioid overdispensing at pharmacies actually disrupts care for patients while making pharmacies anxious too journals.lww.com/journaladdicti…
A4: If you continue to see your provider for buprenorphine, you may need to pay in cash or require prior authorization every time you refill. You also may be required to undergo frequent urine drug testing and a counseling requirement.
These end up being burdensome to patients.
Q: How do you know that people on the street aren't misusing these diverted buprenorphine prescriptions?
A1: There is a growing number of qualitative studies with people who have used buprenorphine on the street. They seek it out for a number of really important reasons.
A1 cont'd:
STUDY: People used non-prescribed buprenorphine for 4 main reasons: too many barriers/demands in treatment, so they could move, to self-initiate treatment, & "to bolster a sense of self-determination and agency in their recovery trajectory"
STUDY: "Our data confirm that NPB use among individuals with opioid use disorder is driven by self-treatment related reasons because nearly 90% reported using NPB in the past 6 months to self-treat opioid withdrawals"
STUDY: "the most frequently cited reasons for non-prescription use were consistent with therapeutic use. Diversion was partially driven by barriers to access, & an unmet need for OUD treatment persists." sciencedirect.com/science/articl…
A2: Trying diverted buprenorphine out on the street can motivate people to get a prescription!
STUDY: "Seeking buprenorphine/naloxone treatment in the previous 12 months was positively associated with using diverted medication in the past 2 months" journals.lww.com/journaladdicti…
A3: Using diverted buprenorphine can reduce overdose risk by avoiding street supply.
STUDY: "higher frequency of non-prescribed buprenorphine use is associated with lower risk of drug overdose, a potential harm reduction consequence of diversion"
TL, DR: The use of diverted buprenorphine is an attempt by people who use drugs to manage the risk of navigating an unregulated drug supply and a policy environment that creates barriers to this life-saving medication. Don't arrest people for helping themselves. FIN
The rate of all-cause mortality for people on Opioid Agonist Treatment (buprenorphine or methadone) was 53% LOWER than the rate when people were not on these medications. (1/x)
“This association was consistent regardless of patient sex, age, geographic location, HIV status, and hepatitis C virus status and whether drugs were taken through injection."
AND
“Associations were not different for methadone vs buprenorphine” (2/x)
The researchers found there was:
➡️52% lower risk of suicide,
➡️28% lower risk of cancer,
➡️59% lower drug-related,
➡️41% lower alcohol-related , and
➡️ 31% lower cardiovascular-related mortality during treatment with buprenorphine or methadone. (3/x)
The drug war and criminalization are the unmeasured confounding variables that impact ALL other variables and outcomes in drug and drug policy research.
We don't even know the full extent of how they impact everything we THINK we know about drugs.
FULL STOP.
(1/x)
Some examples:
➡️Any study about the supposed effects of an illicit drug on emotional, mental, physical health and well-being of users.
As long as the participants used the unmonitored and unregulated illicit supply, you never really know what you're measuring. (2/x)
➡️Any study abt the association btwn illicit drug use & outcomes like risk behaviors, treatment engagement, 'recidivism,' housing, employment, etc.
If ppl fear arrest, incarceration, or having a criminal record bars you from accessing these services, we can't pin it on use (3/x)
This is a bit of a tricky issue to explain, but basically - the DEA wants to preemptively schedule every fentanyl analogue in existence and that will ever exist as a Schedule 1 drug with 'high abuse potential and no medical use.' BUT THIS IS A TERRIBLE IDEA...
1) Not every fentanyl analogue is necessarily even psychoactive, let alone MORE potent than fentanyl.
With class-wide scheduling, someone could get a harsh sentence for trace detectable amounts of a non-psychoactive or less potent fentanyl analogue.
On Monday, JAMA Pediatrics published a new study about the time from drug use initiation to substance use disorder among young people 12-17 and 18-25 for different drugs.
Some politicized it's findings. But they're complicated.
It's tricky to design a study that looks at someone's drug use independent of all their life circumstances and to draw a straight line from that use to the development of a substance use disorder.
Drug use doesn't occur in a bubble.
Though they controlled for some variables like gender, race, family income, ever having a depressive episode, and other substance use disorders, that may not capture other pre-existing personal, social, familial, and environmental factors that may surround a person's drug use.
1) There is clearly this belief that because they are available for free, that somehow every vaccinated person will show up every day for their daily free donut.
They won't. Some might. But that's not how most people work. Most people moderate pleasure.
2) It's also clearly *RICH* to individualize something as policy-driven as sugar consumption, weight, and obesity. An innocent campaign for a free donut isn't going to undo systemic policy choices. (Not my wheelhouse, so I defer to the other tweets on this)
2) Just in time for #NDAFW (National Drug and Alcohol Facts Week) which ends up being a week about fear and stigma, we have released our "10 facts about methamphetamine" page and fact sheet!